According to STAAR Surgical's latest financial reports the company's current revenue (TTM) is $0.32 B. In 2022 the company made a revenue of $0.28 B an increase over the years 2021 revenue that were of $0.23 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.32 B | 13.37% |
2022 | $0.28 B | 23.4% |
2021 | $0.23 B | 41% |
2020 | $0.16 B | 8.84% |
2019 | $0.15 B | 21.16% |
2018 | $0.12 B | 36.8% |
2017 | $90.61 M | 9.92% |
2016 | $82.43 M | 6.88% |
2015 | $77.12 M | 2.85% |
2014 | $74.98 M | 3.84% |
2013 | $72.21 M | 13.22% |
2012 | $63.78 M | 1.63% |
2011 | $62.76 M | 14.2% |
2010 | $54.95 M | -4.59% |
2009 | $57.6 M | -23.09% |
2008 | $74.89 M | 26.16% |
2007 | $59.36 M | 4.55% |
2006 | $56.77 M | 10.67% |
2005 | $51.3 M | -0.74% |
2004 | $51.68 M | 2.53% |
2003 | $50.41 M | 4.7% |
2002 | $48.14 M | -4.16% |
2001 | $50.23 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $49.92 B | 15,384.39% | ๐จ๐ญ Switzerland |
Abbott Laboratories ABT | $40.10 B | 12,340.18% | ๐บ๐ธ USA |
Cooper Companies COO | $3.66 B | 1,037.14% | ๐บ๐ธ USA |
Atrion ATRI | $0.16 B | -47.48% | ๐บ๐ธ USA |
SurgePays SURG | $0.13 B | -57.46% | ๐บ๐ธ USA |